Interleukin-28B rs12979860C/T and rs8099917T/G contribute to spontaneous clearance of hepatitis C virus in Caucasians
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- IL28B inhibits hepatitis C virus replication through the JAK–STAT pathwayJournal of Hepatology, 2011
- A Polymorphism in IL28B Distinguishes Exposed, Uninfected Individuals From Spontaneous Resolvers of HCV InfectionGastroenterology, 2011
- Innate immune genes synergize to predict increased risk of chronic disease in hepatitis C virus infectionProceedings of the National Academy of Sciences, 2011
- Estimating the net contribution of interleukin-28B variation to spontaneous hepatitis C virus clearanceHepatology, 2011
- Hepatitis C Treatment: current and future perspectivesVirology Journal, 2010
- Potential Role for Interleukin-28B Genotype in Treatment Decision-Making in Recent Hepatitis C Virus InfectionHepatology, 2010
- Acute Hepatitis C Virus Infection in Young Adult Injection Drug Users: A Prospective Study of Incident Infection, Resolution, and ReinfectionThe Journal of Infectious Diseases, 2009
- Genetic variation in IL28B and spontaneous clearance of hepatitis C virusNature, 2009
- Lambda Interferon Inhibits Human Immunodeficiency Virus Type 1 Infection of MacrophagesJournal of Virology, 2009
- Measuring inconsistency in meta-analysesBMJ, 2003